Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

DARK SECRETS: 2 | Rare Historical Photos

Coronavirus live updates | Over 169 crore Covid vaccine doses administered in India: Government

India reports fewer COVID-19 deaths than during last week

The Hindu · Feb 6, 2022

Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials

The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.

Dynamite News · Jan 28, 2022

DCGI gives nod to Bharat Biotech for intranasal booster dose trials

Experts have noted that an intranasal vaccine as a booster will be easier to administer in mass vaccination drives.

The Hindu · Jan 28, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

DGCI grants conditional market approval for Covaxin, Covishield

The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.

Dynamite News · Jan 27, 2022

The Bedaquiline Question

One of the increasingly contentious public health issues in India is the manner in which clinical trials are conducted for new drugs and the manner in which these new drugs are subsequently approved for use on Indian patients.

Newslaundry · May 29, 2018

1 2

Coverage From

People

Anand Grover

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.